Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.790
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
1.780
-0.010 (-0.56%)
After-hours: Apr 2, 2026, 7:58 PM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $604.84 million as of April 2, 2026. Its market cap has increased by 277.35% in one year.
Market Cap
604.84M
Enterprise Value
619.41M
1-Year Change
277.35%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $604.84M, an increase of 1,746.86%. That is a compound annual growth rate of 56.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 604.84M | 43.45% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 650.16M |
| LB Pharmaceuticals | 649.93M |
| Crescent Biopharma | 644.35M |
| Alpha Tau Medical | 609.03M |
| Allogene Therapeutics | 604.57M |
| Prime Medicine | 587.90M |
| Aclaris Therapeutics | 583.78M |
| MiMedx Group | 582.38M |